Location: Menlo Park, CA
CIK: 0001631134 · Show all filings
Period: Q1 2025 (← Previous) (Next →)
Filing Date: May 15, 2025
Total Value: $1.531B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| NTRA | Natera Inc | 1,550,280 | $219M | 14.3% | $141.41 * | $9.81 | +1538.7% | COM | 632307104 |
| SYK | Stryker Corporation | 298,567 | $111M | 7.3% | $372.25 | $372.90 | +1.1% | COM | 863667101 |
| QQQ | Invesco QQQ TR | 175,000 | $82.06M | 5.4% | $468.92 | — | — | Put | 46090E103 |
| IWM | iShares TR | 350,000 | $69.82M | 4.6% | $199.49 | — | — | Put | 464287655 |
| VERA | Vera Therapeutics Inc | 2,793,987 | $67.11M | 4.4% | $24.02 * | $15.35 | +109.3% | CL A | 92337R101 |
| JAZZ | Jazz Pharmaceuticals PLC | 510,050 | $63.32M | 4.1% | $124.15 * | $114.95 | +13.5% | SHS USD | G50871105 |
| MDT | Medtronic PLC | 562,992 | $50.59M | 3.3% | $89.86 * | $87.41 | 0.0% | SHS | G5960L103 |
| ALNY | Alnylam Pharmaceuticals Inc | 176,181 | $47.57M | 3.1% | $270.02 * | $260.75 | -1.4% | COM | 02043Q107 |
| GILD | Gilead Sciences Inc | 418,900 | $46.94M | 3.1% | $112.05 * | $87.00 | +15.5% | COM | 375558103 |
| LLY | Eli Lilly & Co | 52,800 | $43.61M | 2.8% | $825.91 | $825.18 | +0.2% | COM | 532457108 |
| IDYA | IDEAYA Biosciences Inc | 2,622,192 | $42.95M | 2.8% | $16.38 * | $25.35 | -15.9% | COM | 45166A102 |
| SLNO | Soleno Therapeutics Inc | 529,300 | $37.82M | 2.5% | $71.45 * | $45.28 | +7.5% | Put | 834203309 |
| SLNO | Soleno Therapeutics Inc | 484,471 | $34.62M | 2.3% | $71.45 * | $45.28 | +7.5% | COM | 834203309 |
| AVBP | Arrivent BioPharma Inc | 1,696,752 | $31.37M | 2.0% | $18.49 * | $20.17 | +21.3% | COM | 04272N102 |
| PTCT | PTC Therapeutics Inc | 579,339 | $29.52M | 1.9% | $50.96 * | $49.90 | 0.0% | COM | 69366J200 |
| SNDX | Syndax Pharmaceuticals Inc | 2,275,223 | $27.95M | 1.8% | $12.29 * | $16.13 | -12.6% | COM | 87164F105 |
| DXCM | Dexcom Inc | 395,975 | $27.04M | 1.8% | $68.29 * | $76.06 | +7.3% | COM | 252131107 |
| BBIO | BridgeBio Pharma Inc | 734,227 | $25.38M | 1.7% | $34.57 * | $33.72 | 0.0% | COM | 10806X102 |
| REPL | Replimune Group Inc | 2,479,939 | $24.18M | 1.6% | $9.75 * | $12.12 | +2.1% | COM | 76029N106 |
| RYTM | Rhythm Pharmaceuticals | 446,839 | $23.67M | 1.5% | $52.97 * | $50.73 | +9.4% | COM | 76243J105 |
| INSM | Insmed Inc | 304,254 | $23.21M | 1.5% | $76.29 | $50.76 | +50.7% | COM PAR $.01 | 457669307 |
| — | Blueprint Medicines Corp | 261,039 | $23.1M | 1.5% | $88.51 | $88.51 | — | COM | 09627Y109 |
| BMY | Bristol-Myers Squibb Co | 371,497 | $22.66M | 1.5% | $60.99 * | $55.48 | 0.0% | COM | 110122108 |
| INCY | Incyte Corp | 357,800 | $21.66M | 1.4% | $60.55 * | $63.77 | +9.4% | COM | 45337C102 |
| ANAB | AnaptysBio Inc | 1,160,033 | $21.57M | 1.4% | $18.59 * | $17.55 | -4.9% | COM | 032724106 |
| SRPT | Sarepta Therapeutics Inc | 327,618 | $20.91M | 1.4% | $63.82 * | $122.55 | -14.1% | COM | 803607100 |
| — | Akero Therapeutics Inc | 510,020 | $20.65M | 1.3% | $40.48 | $40.48 | — | COM | 00973Y108 |
| AXSM | Axsome Therapeutics Inc | 175,317 | $20.45M | 1.3% | $116.63 * | $80.00 | +42.4% | COM | 05464T104 |
| RAPP | Rapport Therapeutics Inc | 1,995,594 | $20.02M | 1.3% | $10.03 * | $23.12 | -43.8% | COM | 75383L102 |
| SUPN | Supernus Pharmaceuticals Inc | 520,678 | $17.05M | 1.1% | $32.75 * | $35.44 | 0.0% | COM | 868459108 |
| SVRA | Savara Inc | 5,481,666 | $15.18M | 1.0% | $2.77 | $4.16 | -33.7% | COM | 805111101 |
| COGT | Cogent Biosciences Inc | 2,182,121 | $13.07M | 0.9% | $5.99 * | $7.29 | +7.6% | COM | 19240Q201 |
| ROIV | Roivant Sciences Ltd | 1,279,510 | $12.91M | 0.8% | $10.09 * | $10.81 | 0.0% | SHS | G76279101 |
| DHR | Danaher Corporation | 58,606 | $12.01M | 0.8% | $205.00 * | $221.58 | -2.1% | COM | 235851102 |
| PEN | Penumbra Inc | 42,936 | $11.48M | 0.7% | $267.41 | $270.50 | 0.0% | COM | 70975L107 |
| RNAM | Avidity Biosciences Inc | 379,931 | $11.22M | 0.7% | $29.52 * | $31.21 | -0.2% | COM | 05370A108 |
| INBX | Inhibrx Biosciences Inc | 697,916 | $9.764M | 0.6% | $13.99 * | $14.96 | -9.2% | COM | 45720N103 |
| — | Y-mAbs Therapeutics Inc | 2,194,278 | $9.721M | 0.6% | $4.43 | $26.75 | — | COM | 984241109 |
| — | Aerovate Therapeutics Inc | 3,758,686 | $9.434M | 0.6% | $2.51 | $22.83 | — | COM | 008064107 |
| PHVS | Pharvaris N V | 593,403 | $9.316M | 0.6% | $15.70 * | $20.79 | -18.9% | COM | N69605108 |
| BIOA | BioAge Labs Inc | 2,304,901 | $8.666M | 0.6% | $3.76 * | $20.04 | -76.9% | COM | 09077V100 |
| ACAD | ACADIA Pharmaceuticals Inc | 500,000 | $8.305M | 0.5% | $16.61 | — | — | Call | 004225108 |
| RCUS | Arcus Biosciences Inc | 1,037,776 | $8.147M | 0.5% | $7.85 * | $11.59 | 0.0% | COM | 03969F109 |
| EWTX | Edgewise Therapeutics Inc | 342,218 | $7.529M | 0.5% | $22.00 * | $18.09 | +45.1% | COM | 28036F105 |
| DYN | Dyne Therapeutics Inc | 716,896 | $7.499M | 0.5% | $10.46 * | $20.14 | -29.0% | COM | 26818M108 |
| EWTX | Edgewise Therapeutics Inc | 320,400 | $7.049M | 0.5% | $22.00 * | $18.09 | +45.1% | Put | 28036F105 |
| IMTX | Immatics N.V | 1,554,304 | $7.01M | 0.5% | $4.51 * | $6.24 | -16.4% | SHS | N44445109 |
| PRAX | Praxis Precision Medicines I | 157,640 | $5.97M | 0.4% | $37.87 * | $62.45 | 0.0% | COM | 74006W207 |
| ISRG | Intuitive Surgical Inc | 11,984 | $5.935M | 0.4% | $495.27 * | $520.85 | +6.2% | COM | 46120E602 |
| QURE | Uniqure NV | 545,771 | $5.785M | 0.4% | $10.60 * | $14.02 | 0.0% | SHS | N90064101 |
| IMNM | Immunome Inc | 788,666 | $5.308M | 0.3% | $6.73 * | $18.47 | -48.1% | COM | 45257U108 |
| KURA | Kura Oncology Inc | 791,667 | $5.225M | 0.3% | $6.60 * | $7.79 | 0.0% | COM | 50127T109 |
| — | Inozyme Pharma Inc | 4,280,308 | $3.895M | 0.3% | $0.91 | $14.88 | — | COM | 45790W108 |
| SRRK | Scholar Rock Hldg Corp | 116,117 | $3.733M | 0.2% | $32.15 * | $38.47 | 0.0% | COM | 80706P103 |
| ERAS | Erasca Inc | 1,877,085 | $2.572M | 0.2% | $1.37 * | $2.19 | -21.6% | COM | 29479A108 |
| — | Nextcure Inc | 2,671,856 | $1.283M | 0.1% | $0.48 | $10.01 | — | COM | 65343E108 |
| ESTA | Establishment Labs Hldgs Inc | 28,675 | $1.17M | 0.1% | $40.80 * | $47.17 | -21.0% | COM | G31249108 |
| — | Bolt Biotherapeutics Inc | 2,754,437 | $1.102M | 0.1% | $0.40 | $32.91 | — | COM | 097702104 |
| — | Metsera Inc | 36,800 | $1.002M | 0.1% | $27.22 | $27.22 | — | COM | 59267L107 |
| ELVN | Enliven Therapeutics Inc | 33,547 | $660K | 0.0% | $19.68 * | $25.92 | -17.0% | COM | 29337E102 |
| GPCR | Structure Therapeutics Inc | 34,952 | $605K | 0.0% | $17.31 | $34.06 | — | SPONSORED ADS | 86366E106 |
| VIR | Vir Biotechnology Inc | 83,010 | $538K | 0.0% | $6.48 * | $8.69 | +2.4% | COM | 92764N102 |
| — | Ikena Oncology Inc | 382,616 | $490K | 0.0% | $1.28 | $2.66 | — | COM | 45175G108 |
| IRON | Disc Medicine Inc | 7,485 | $372K | 0.0% | $49.64 * | $42.38 | +31.2% | COM | 254604101 |